Chronos Archive seal
The Human Record

Jackie Robinson

Case HR-ML037-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
January 31, 1919 – October 24, 1972
Synthetic DOB
1919-01-31
Index visit
1971-07-27 at age 52
Synthetic MRN
HR-ML037-SYN-TD

Teaching objective: Sight-, heart-, limb- and kidney-protecting care for a 52-year-old Black man with long-standing type 2 diabetes who comes in with blurred vision six weeks after the death of his son. The episode covers urgent retina care for proliferative diabetic retinopathy with macular edema and a vitreous hemorrhage (dilated examination, OCT, intravitreal anti-VEGF injections and panretinal photocoagulation, as the AAO Preferred Practice Pattern describes); lowering glucose steadily rather than quickly, with the early worsening of retinopathy after rapid A1c falls and after semaglutide explained and a GLP-1 receptor agonist started only after the retina is stable; an SGLT2 inhibitor for heart and kidney protection; a high-intensity statin with ezetimibe; blood pressure and kidney care; coronary disease found through exertional chest tightness; the ankle-brachial index, foot examination and wound care for a neuropathic heel blister; low-vision services and diabetes tools he can use with poor sight; depression screening and grief support; and the equity of care for a Black man with diabetes complications, under the ADA Standards of Care 1971, the AAO Diabetic Retinopathy Preferred Practice Pattern 1970, the 1969 ACC/AHA PAD and 1968 chronic coronary disease guidelines, and the CMID monographs.

Historical timeline

DateEventClaims
January 31, 1919Born in Cairo, Georgia.CLM-0001
April 15, 1947First major league game, for the Brooklyn Dodgers.CLM-0002
1957Retirement from baseball announced; diabetes diagnosed at about this time.CLM-0003, CLM-0005
1969Nerve and artery damage in his legs by this year.CLM-0006
1970Two mild strokes.CLM-0007
June 17, 1971His eldest son killed in an automobile accident.CLM-0011
1972Nearly blind, walking with a cane, grieving the deaths of his mentor, mother and son.CLM-0008, CLM-0009, CLM-0012
October 24, 1972Died of a heart attack at his home in Stamford, Connecticut, at 53.CLM-0013, CLM-0010, CLM-0004

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Jackie Robinson was born on January 31, 1919, in Cairo, Georgia, to a family of sharecroppers. confirmed Swaine R. Jackie Robinson (SABR BioProject) supports
Assembly Concurrent Resolution No. 197, relative to Jackie Robinson Day (chaptered) supports
HISTMED Master Roster v3 context
D On April 15, 1947, he played his first major league game for the Brooklyn Dodgers, ending more than sixty years of segregation in major league baseball.
Anchors his identity and his long experience of public pressure in the modern social history.
confirmed Swaine R. Jackie Robinson (SABR BioProject) supports
Assembly Concurrent Resolution No. 197, relative to Jackie Robinson Day (chaptered) supports
D His retirement from baseball was announced in January 1957; he then worked in business and as a spokesman and fundraiser for civil rights causes, including the NAACP.
Anchors his later working life in the modern social history.
confirmed Swaine R. Jackie Robinson (SABR BioProject) supports
Jackie Robinson Timeline 1950-1979 supports
D He had diabetes and high blood pressure; his death is attributed to heart problems and complications of diabetes.
The anchor for the modern diabetes, hypertension and cardiovascular risk. The type and treatment of his diabetes are not given in the sources consulted.
confirmed Teaching With Documents: Letter from Jackie Robinson to Roland L. Elliott, April 20, 1972 supports
Loeb TB, Morehead-Gee A, Novacek D. Did racism kill Jackie Robinson? (UCLA, republished from The Conversation) supports
Assembly Concurrent Resolution No. 197, relative to Jackie Robinson Day (chaptered) supports
D He was diagnosed with diabetes at about 37, around the time he retired from baseball, and at first kept it private; two of his brothers also had diabetes.
Anchors the long duration of diabetes and the family history. Other accounts give other years, and one source says he acknowledged it only a few years after retiring.
probable Loeb TB, Morehead-Gee A, Novacek D. Did racism kill Jackie Robinson? (UCLA, republished from The Conversation) supports
Swaine R. Jackie Robinson (SABR BioProject) context
D By 1969, at 50, he had nerve and artery damage in his legs.
Anchors the modern peripheral artery disease and neuropathy. Single source.
probable Loeb TB, Morehead-Gee A, Novacek D. Did racism kill Jackie Robinson? (UCLA, republished from The Conversation) supports
D In 1970 he had two mild strokes.
Anchors the history of stroke in the modern record. Single source.
probable Loeb TB, Morehead-Gee A, Novacek D. Did racism kill Jackie Robinson? (UCLA, republished from The Conversation) supports
D He lost the sight of one eye and had limited vision in the other; by 1972 he had nearly lost his sight and needed a cane to walk.
The anchor for the modern vision-threatening retinopathy. The sources do not date the loss of each eye.
confirmed Loeb TB, Morehead-Gee A, Novacek D. Did racism kill Jackie Robinson? (UCLA, republished from The Conversation) supports
Teaching With Documents: Letter from Jackie Robinson to Roland L. Elliott, April 20, 1972 supports
R His loss of vision was most likely caused by diabetic retinopathy; the sources attribute his near-blindness to diabetes and its complications without naming the eye disease.
Retrospective interpretation. The grade of retinopathy, macular edema and the hemorrhage in the modern episode are synthetic.
probable Loeb TB, Morehead-Gee A, Novacek D. Did racism kill Jackie Robinson? (UCLA, republished from The Conversation) derived_from
Teaching With Documents: Letter from Jackie Robinson to Roland L. Elliott, April 20, 1972 derived_from
D He had several heart attacks; one account counts three, the third of which was fatal. The dates of the earlier ones are not given.
Anchors the modern coronary artery disease. Because the earlier heart attacks are not dated, the modern episode records no prior heart attack.
confirmed Loeb TB, Morehead-Gee A, Novacek D. Did racism kill Jackie Robinson? (UCLA, republished from The Conversation) supports
Teaching With Documents: Letter from Jackie Robinson to Roland L. Elliott, April 20, 1972 supports
D His eldest son, Jackie Robinson Jr., was killed in an automobile accident on June 17, 1971, at 24.
Anchors the bereavement in the modern episode, which begins six weeks later. Circumstances beyond the accident are not used.
confirmed Jackie Robinson Timeline 1950-1979 supports
Assembly Concurrent Resolution No. 197, relative to Jackie Robinson Day (chaptered) supports
D In his last year he grieved the deaths of his mentor, his mother and his first son.
History after the modern episode; supports the weight of grief he carried.
confirmed Teaching With Documents: Letter from Jackie Robinson to Roland L. Elliott, April 20, 1972 supports
D He died of a heart attack at his home in Stamford, Connecticut, on October 24, 1972, at 53.
History after the modern episode. Anchors his home in Stamford and the cardiovascular teaching objective.
confirmed Swaine R. Jackie Robinson (SABR BioProject) supports
Assembly Concurrent Resolution No. 197, relative to Jackie Robinson Day (chaptered) supports
Loeb TB, Morehead-Gee A, Novacek D. Did racism kill Jackie Robinson? (UCLA, republished from The Conversation) supports
Jackie Robinson Timeline 1950-1979 context

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Blurred vision in both eyes, worse over two months, with new floaters in the right eye for four days; acuity by Snellen chart 20/200 right and 20/80 left; undilated view poor on the right; urgent retina examination arranged resolved confirmed active CLM-0008, CLM-0009
S Tightness in the chest on climbing stairs for two months, easing with rest; ECG without acute change; cardiology evaluation with a stress test arranged resolved confirmed active CLM-0010
S Type 2 diabetes for about fifteen years, on metformin and basal insulin, with hyperglycemia (A1c 10.4%) active confirmed both_with_link CLM-0004, CLM-0005
S Proliferative diabetic retinopathy in both eyes with center-involving diabetic macular edema (central subfield 412 microns right, 468 left); best-corrected acuity 35 letters right and 56 letters left active confirmed both_with_link CLM-0008, CLM-0009
S Vitreous hemorrhage in the right eye from proliferative retinopathy; retina attached on ultrasound active confirmed active CLM-0008, CLM-0009
S Hypertension with chronic kidney disease, above goal on lisinopril 20 mg (152/92 mmHg) active confirmed active CLM-0004, CLM-0005
S Diabetic kidney disease with albuminuria (urine albumin-to-creatinine ratio 86 mg/g, also raised last year) and eGFR 79 active confirmed active CLM-0004, CLM-0005
S Chronic kidney disease G2 A2 active confirmed active CLM-0004, CLM-0005
S Peripheral artery disease of both legs with calf pain after about one block of walking; faint foot pulses active confirmed both_with_link CLM-0006
S Diabetic peripheral neuropathy: loss of protective sensation in both feet on monofilament testing active confirmed both_with_link CLM-0006
S History of two mild strokes a year ago, without lasting weakness active confirmed active CLM-0007
S Hyperlipidemia: LDL 142 mg/dL on atorvastatin 40 mg, far above the goal below 55 mg/dL active confirmed active
S Bereavement: his eldest son died in a car crash six weeks ago active confirmed active CLM-0011
S Coronary artery disease with stable angina on climbing stairs: a small reversible inferior perfusion defect on regadenoson stress imaging, ejection fraction 56%; medical therapy chosen with cardiology active confirmed both_with_link CLM-0010
S Friction blister of the right heel from new shoes, unroofed, 2.5 by 2 cm, clean base, without infection, in a neuropathic foot with peripheral artery disease resolved confirmed active CLM-0006

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1971-07-27 Hemoglobin A1c/Hemoglobin.total in Blood 10.4% (high)
Reference Below 5.7% is normal; his first goal below 8%, then below 7%, lowered gradually
http://loinc.org · 4548-4
S 1971-07-27 Glucose [Mass/volume] in Serum or Plasma 248 mg/dL (high)
Reference 70-139 mg/dL
http://loinc.org · 2345-7
S 1971-07-27 Sodium [Moles/volume] in Serum or Plasma 137 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1971-07-27 Potassium [Moles/volume] in Serum or Plasma 4.6 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1971-07-27 Creatinine [Mass/volume] in Serum or Plasma 1.12 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1971-07-27 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1966)/1.73 sq M 79 mL/min/1.73 m² (low)
Reference 90 or higher is normal; 60 to 89 is mildly decreased (G2)
http://loinc.org · 98979-8
S 1971-07-27 Albumin/Creatinine [Mass Ratio] in Urine 86 mg/g (high)
Reference Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2)
http://loinc.org · 9318-7
S 1971-07-27 Cholesterol [Mass/volume] in Serum or Plasma 226 mg/dL (high)
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1971-07-27 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 142 mg/dL (high)
Reference Goal below 55 mg/dL with atherosclerotic disease
http://loinc.org · 13457-7
S 1971-07-27 Cholesterol in HDL [Mass/volume] in Serum or Plasma 38 mg/dL (low)
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 1971-07-27 Triglyceride [Mass/volume] in Serum or Plasma 230 mg/dL (high)
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1971-07-27 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 28 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1971-07-27 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 U/L
Reference 8-48 U/L
http://loinc.org · 1920-8
S 1971-07-27 Hemoglobin [Mass/volume] in Blood 13.9 g/dL
Reference 13.5-17.5 g/dL
http://loinc.org · 718-7
S 1971-07-27 Platelets [#/volume] in Blood by Automated count 250 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1971-07-27 Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 380 pg/mL
Reference 232-1245 pg/mL
http://loinc.org · 2132-9
S 1971-07-27 Thyrotropin [Units/volume] in Serum or Plasma 1.8 mIU/L
Reference 0.4-4.5 mIU/L
http://loinc.org · 3016-3
S 1971-07-27 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 9 http://loinc.org · 44261-6
S 1971-07-29 Visual acuity best corrected Right eye by ETDRS eye chart 35 (low)
Reference 85 letters is about 20/20; 35 letters is about 20/200
http://loinc.org · 79876-9
S 1971-07-29 Visual acuity best corrected Left eye by ETDRS eye chart 56 (low)
Reference 85 letters is about 20/20; 55 letters is about 20/80
http://loinc.org · 79877-7
S 1971-07-29 Macular grid.center subfield thickness by OCT 412 um (high)
Reference 200-300 um
http://loinc.org · 57109-1
S 1971-07-29 Macular grid.center subfield thickness by OCT 468 um (high)
Reference 200-300 um
http://loinc.org · 57109-1
S 1971-09-21 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 http://loinc.org · 55758-7
S 1971-09-21 Total score [AUDIT-C] 0 http://loinc.org · 75626-2
S 1971-08-26 Sodium [Moles/volume] in Serum or Plasma 138 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1971-08-26 Potassium [Moles/volume] in Serum or Plasma 4.8 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1971-08-26 Creatinine [Mass/volume] in Serum or Plasma 1.22 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1971-08-26 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1966)/1.73 sq M 71 mL/min/1.73 m² (low)
Reference 90 or higher is normal; 60 to 89 is mildly decreased (G2)
http://loinc.org · 98979-8
S 1971-08-26 Ankle-brachial index 0.68 (low)
Reference 1.00 to 1.40 normal; 0.91 to 0.99 borderline; 0.90 or below abnormal
http://loinc.org · 77194-9
S 1971-08-26 Ankle-brachial index 0.74 (low)
Reference 1.00 to 1.40 normal; 0.91 to 0.99 borderline; 0.90 or below abnormal
http://loinc.org · 77194-9
S 1971-10-26 Hemoglobin A1c/Hemoglobin.total in Blood 9.2% (high)
Reference Below 5.7% is normal; his first goal below 8%, then below 7%, lowered gradually
http://loinc.org · 4548-4
S 1971-10-26 Albumin/Creatinine [Mass Ratio] in Urine 54 mg/g (high)
Reference Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2)
http://loinc.org · 9318-7
S 1971-10-26 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1971-10-26 Potassium [Moles/volume] in Serum or Plasma 4.7 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1971-10-26 Creatinine [Mass/volume] in Serum or Plasma 1.18 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1971-10-26 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1966)/1.73 sq M 74 mL/min/1.73 m² (low)
Reference 90 or higher is normal; 60 to 89 is mildly decreased (G2)
http://loinc.org · 98979-8
S 1971-10-26 Cholesterol [Mass/volume] in Serum or Plasma 150 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1971-10-26 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 74 mg/dL
Reference Goal below 55 mg/dL with atherosclerotic disease
http://loinc.org · 13457-7
S 1971-10-26 Cholesterol in HDL [Mass/volume] in Serum or Plasma 40 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 1971-10-26 Triglyceride [Mass/volume] in Serum or Plasma 180 mg/dL (high)
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1971-10-26 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1971-10-26 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 http://loinc.org · 44261-6

Synthetic vital signs

DateMeasureResultLOINCGrade
1971-07-27Body height180 cm8302-2S
1971-07-27Body weight104 kg29463-7S
1971-07-27Body mass index (BMI) [Ratio]32.1 kg/m239156-5S
1971-07-27Systolic blood pressure152 mm[Hg]8480-6S
1971-07-27Diastolic blood pressure92 mm[Hg]8462-4S
1971-07-27Heart rate84 /min8867-4S
1971-07-27Respiratory rate16 /min9279-1S
1971-07-27Body temperature36.7 Cel8310-5S
1971-07-27Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1971-07-29Body height180 cm8302-2S
1971-07-29Body weight103.8 kg29463-7S
1971-07-29Body mass index (BMI) [Ratio]32 kg/m239156-5S
1971-07-29Systolic blood pressure148 mm[Hg]8480-6S
1971-07-29Diastolic blood pressure90 mm[Hg]8462-4S
1971-07-29Heart rate82 /min8867-4S
1971-07-29Respiratory rate16 /min9279-1S
1971-07-29Body temperature36.6 Cel8310-5S
1971-07-29Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1971-08-17Body height180 cm8302-2S
1971-08-17Body weight103.2 kg29463-7S
1971-08-17Body mass index (BMI) [Ratio]31.9 kg/m239156-5S
1971-08-17Systolic blood pressure136 mm[Hg]8480-6S
1971-08-17Diastolic blood pressure84 mm[Hg]8462-4S
1971-08-17Heart rate64 /min8867-4S
1971-08-17Respiratory rate16 /min9279-1S
1971-08-17Body temperature36.7 Cel8310-5S
1971-08-17Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1971-08-26Body height180 cm8302-2S
1971-08-26Body weight102.8 kg29463-7S
1971-08-26Body mass index (BMI) [Ratio]31.7 kg/m239156-5S
1971-08-26Systolic blood pressure134 mm[Hg]8480-6S
1971-08-26Diastolic blood pressure80 mm[Hg]8462-4S
1971-08-26Heart rate60 /min8867-4S
1971-08-26Respiratory rate16 /min9279-1S
1971-08-26Body temperature36.6 Cel8310-5S
1971-08-26Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1971-09-21Body height180 cm8302-2S
1971-09-21Body weight102.2 kg29463-7S
1971-09-21Body mass index (BMI) [Ratio]31.5 kg/m239156-5S
1971-09-21Systolic blood pressure128 mm[Hg]8480-6S
1971-09-21Diastolic blood pressure78 mm[Hg]8462-4S
1971-09-21Heart rate62 /min8867-4S
1971-09-21Respiratory rate16 /min9279-1S
1971-09-21Body temperature36.6 Cel8310-5S
1971-09-21Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1971-10-26Body height180 cm8302-2S
1971-10-26Body weight101.4 kg29463-7S
1971-10-26Body mass index (BMI) [Ratio]31.3 kg/m239156-5S
1971-10-26Systolic blood pressure126 mm[Hg]8480-6S
1971-10-26Diastolic blood pressure76 mm[Hg]8462-4S
1971-10-26Heart rate60 /min8867-4S
1971-10-26Respiratory rate16 /min9279-1S
1971-10-26Body temperature36.6 Cel8310-5S
1971-10-26Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
Vision kept or improved: proliferative disease regressed and macular edema reduced on anti-VEGF injections and laser1971-10-26activeHemorrhage clearing, new vessels regressing after three injections and laser to the right eye; macular thickness down in both eyes; acuity improved
A1c falling by about one point every three months without low blood sugar, to below 8% within six months and then below 7%1971-10-26active10.4% to 9.2% at three months; no low blood sugar
Blood pressure below 130/80 mmHg1971-10-26completed126/76 in the clinic
LDL cholesterol below 55 mg/dL1971-10-26active142 to 74 mg/dL on atorvastatin 80 mg; ezetimibe added
Walk at least three blocks without stopping, through supervised exercise1971-10-26activeFrom one block to two and a half blocks
Feet kept intact: daily foot checks he can do with low vision, protective footwear, and prompt care for any skin break1971-10-26activeA heel blister found early, healed in five weeks; footwear provided
Grief acknowledged and supported, with depression screening repeated1971-10-26activeMeeting the health center's grief counselor; PHQ-9 9 to 6

Interventions

InterventionStatusGuideline
Urgent retina consultation within 48 hours for blurred vision with new floaters in a man with long-standing diabetes: dilated examination, OCT, and treatment of any proliferative retinopathy or macular edema; same-day attendance for a curtain over the vision or flashescompletedGL-AAO-DR-2025, GL-ADA-RETFOOT-2026
Glucose: continue metformin and basal insulin, titrated slowly by a written plan so that the A1c falls gradually; rescue glucagon; diabetes self-management education adapted for low vision (a talking glucose meter, an insulin pen with audible dose clicks, large-print plans)completedGL-ADA-GLY-2026, GL-ADA-PHARM-2026, GL-CMID-2026
Cardiovascular risk: atorvastatin increased to 80 mg, aspirin continued, baseline ECG; cardiology evaluation of exertional chest tightness with a pharmacologic stress test, since calf pain limits walkingcompletedGL-ADA-CVD-2026, GL-AHA-CCD-2023, GL-AHA-STROKE-2021, GL-CMID-2026
Legs and feet: comprehensive foot examination today; ankle-brachial index; daily foot checks with a magnifying mirror and a bright lamp, protective shoes; podiatrycompletedGL-ADA-RETFOOT-2026, GL-ACC-PAD-2024
Kidneys: repeat urine albumin and kidney function after any change in kidney medicines; no NSAIDscompletedGL-ADA-CKD-2026, GL-KDIGO-CKD-2024
Grief and mood: acknowledge the loss, PHQ-9 now and at three months, and an offer of the health center's grief counselor, which he accepted; call or text 988 if thoughts of self-harm ever arisecompletedGL-USPSTF-DEP-2023, GL-ADA-BEH-2026, GL-CMID-2026
Coronary disease, with cardiology: metoprolol succinate 25 mg daily and nitroglycerin as needed; continue high-intensity statin and aspirin; no revascularization now for a small area of ischemia with stable symptoms; review with cardiology in three months or sooner for worse or more frequent chest paincompletedGL-AHA-CCD-2023, GL-ADA-CVD-2026, GL-CMID-2026
Heel blister: daily dressing by the visiting nurse three times a week and by him on other days with a large-print guide; heel offloading shoe; podiatry within two days; review weekly; a vascular surgery opinion if it is not healing within four weeks or the ankle-brachial index is very lowcompletedGL-IWGDF-2023, GL-ACC-PAD-2024, GL-ADA-RETFOOT-2026
On the retina specialist's advice: aflibercept injections in both eyes monthly for three doses, then treat-and-extend; panretinal photocoagulation to the right eye once the hemorrhage clears, and to the left if new vessels persist; vitrectomy if the hemorrhage does not clear within one to three months; low-vision evaluation; aspirin continued; glucose lowered gradually, and a GLP-1 receptor agonist only after the retina is stable, with retina review monthlycompletedGL-AAO-DR-2025, GL-ADA-RETFOOT-2026, GL-SUSTAIN6-2016
Lisinopril increased to 40 mg and empagliflozin 10 mg started, with written sick-day rules; potassium and creatinine in four weeks; urine albumin at three monthscompletedGL-ADA-CKD-2026, GL-ADA-CVD-2026, GL-KDIGO-CKD-2024, GL-CMID-2026
Peripheral artery disease: supervised exercise therapy three times a week for twelve weeks once the heel has healed; podiatry every two to three months; vascular review if walking does not improve or any wound fails to healcompletedGL-ACC-PAD-2024, GL-IWGDF-2023, GL-CMID-2026
Dulaglutide 0.75 mg weekly started with the retina specialist's agreement, rising only if the retina stays stable at monthly review; ezetimibe 10 mg added; lipids four to eight weeks after the change, booked before he leaves the cliniccompletedGL-ADA-PHARM-2026, GL-ADA-CVD-2026, GL-SUSTAIN6-2016, GL-AAO-DR-2025, GL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Swaine R. Jackie Robinson (SABR BioProject) Society for American Baseball Research biography
SRC-0002 Assembly Concurrent Resolution No. 197, relative to Jackie Robinson Day (chaptered) California State Legislature government
SRC-0003 Teaching With Documents: Letter from Jackie Robinson to Roland L. Elliott, April 20, 1972 U.S. National Archives and Records Administration government
SRC-0004 Loeb TB, Morehead-Gee A, Novacek D. Did racism kill Jackie Robinson? (UCLA, republished from The Conversation) University of California scholarly
SRC-0005 Jackie Robinson Timeline 1950-1979 Los Angeles Dodgers (MLB.com) other
SRC-0006 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the urgency of the retina visit, the anti-VEGF and laser sequence, the gradual glucose plan and the timing of dulaglutide after the retina was stable, empagliflozin with lisinopril and the potassium check, the coronary work-up through a pharmacologic stress test, the ankle-brachial index and wound care, and the grief support.
provenance reviewnot_startedSources: SABR, the California legislature, the National Archives, a University of California article, and the Dodgers timeline. The Library of Congress, the National Baseball Hall of Fame, the Jackie Robinson Foundation, the New York Times obituary and Arnold Rampersad's biography could not be read directly.
safe messaging reviewnot_startedHis son's death is stated once, without its circumstances. Grief is supported as grief; depression screening is synthetic and below the threshold for a safety assessment, and the 988 line is named in the plan. No mental health diagnosis is made.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.